91ÖÆƬ³§

Published on Market Research Reports® Inc. ()

Home > Global Biopharmaceutical Logistic Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Biopharmaceutical Logistic Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Publication ID: 
PB504252112
Publication Date: 
April 15, 2025
Pages: 
104
Publisher: 
MRRPB5
Countries: 
Global [1]
USD 4,250.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

IT Services [2]
Computing & Electronics [3]
Description: 

The global Biopharmaceutical Logistic market size was US$ 92500 million in 2024 and is forecast to a readjusted size of US$ 120460 million by 2031 with a CAGR of 3.9% during the forecast period 2025-2031.
Biopharmaceutical Logistics is the logistics of Biopharmaceutical, medical and surgical supplies, and other products needed to support doctors, nurses, and other health and dental care providers. Because it’s final customers are responsible for the lives and health of their patients, medical logistics is unique in that it seeks to optimize effectiveness rather than efficiency. Medical logistics functions comprise an important part of the health care system: after staff costs, medical supplies are the single most expensive component of health care. To drive costs out of the health-care sector, medical logistics providers are adopting supply chain management theories.
Market competition is intense. Deutsche Post DHL, Kuehne + Nagel, FedEx, AmerisourceBergen, UPS (Marken) and DB Schenker, etc. are the leaders of the industry, and they hold key technologies, with high-end customers; have been formed in the monopoly position in the industry. The top six players got about 20% market shares. North America is the largest consumption place, with a consumption market share nearly 34%. Following North America, Europe is the second largest consumption place with the consumption market share of 30%.
The global Biopharmaceutical Logistic market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Deutsche Post DHL
Kuehne + Nagel
FedEx
AmerisourceBergen
UPS (Marken)
DB Schenker
XPO Logistics
Panalpina
Nippon Express
GEODIS
VersaCold
Agility
DSV
Sinotrans
Kerry Logistics
SF Express
CEVA
CH Robinson
Air Canada Cargo
By Type: (Dominant Segment vs High-Margin Innovation)
Cold Chain Logistics
Non-cold Chain Logistics
By Application: (Core Demand Driver vs Emerging Opportunity)
Ground Shipping
Sea Shipping
Air Shipping
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Deutsche Post DHL in Europe)
- Emerging Product Trends: Cold Chain Logistics adoption vs. Non-cold Chain Logistics premiumization
- Demand-Side Dynamics: Ground Shipping growth in China vs. Sea Shipping potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Biopharmaceutical Logistic market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Non-cold Chain Logistics in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Sea Shipping in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Biopharmaceutical Logistic value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Cold Chain Logistics
1.2.3 Non-cold Chain Logistics
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Ground Shipping
1.3.3 Sea Shipping
1.3.4 Air Shipping
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical Logistic Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Biopharmaceutical Logistic Revenue Market Share by Region (2020-2025)
2.4 Global Biopharmaceutical Logistic Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Biopharmaceutical Logistic Market Size and Prospective (2020-2031)
2.5.2 Europe Biopharmaceutical Logistic Market Size and Prospective (2020-2031)
2.5.3 China Biopharmaceutical Logistic Market Size and Prospective (2020-2031)
2.5.4 Japan Biopharmaceutical Logistic Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Biopharmaceutical Logistic Historic Market Size by Type (2020-2025)
3.2 Global Biopharmaceutical Logistic Forecasted Market Size by Type (2026-2031)
3.3 Different Types Biopharmaceutical Logistic Representative Players
4 Breakdown Data by Application
4.1 Global Biopharmaceutical Logistic Historic Market Size by Application (2020-2025)
4.2 Global Biopharmaceutical Logistic Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Biopharmaceutical Logistic Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Biopharmaceutical Logistic Players by Revenue (2020-2025)
5.1.2 Global Biopharmaceutical Logistic Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Biopharmaceutical Logistic Revenue
5.4 Global Biopharmaceutical Logistic Market Concentration Analysis
5.4.1 Global Biopharmaceutical Logistic Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Logistic Revenue in 2024
5.5 Global Key Players of Biopharmaceutical Logistic Head office and Area Served
5.6 Global Key Players of Biopharmaceutical Logistic, Product and Application
5.7 Global Key Players of Biopharmaceutical Logistic, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Biopharmaceutical Logistic Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Biopharmaceutical Logistic Market Size by Type (2020-2025)
6.1.2.2 North America Biopharmaceutical Logistic Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Biopharmaceutical Logistic Market Size by Application (2020-2025)
6.1.3.2 North America Biopharmaceutical Logistic Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Biopharmaceutical Logistic Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Biopharmaceutical Logistic Market Size by Type (2020-2025)
6.2.2.2 Europe Biopharmaceutical Logistic Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Biopharmaceutical Logistic Market Size by Application (2020-2025)
6.2.3.2 Europe Biopharmaceutical Logistic Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Biopharmaceutical Logistic Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Biopharmaceutical Logistic Market Size by Type (2020-2025)
6.3.2.2 China Biopharmaceutical Logistic Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Biopharmaceutical Logistic Market Size by Application (2020-2025)
6.3.3.2 China Biopharmaceutical Logistic Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Biopharmaceutical Logistic Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Biopharmaceutical Logistic Market Size by Type (2020-2025)
6.4.2.2 Japan Biopharmaceutical Logistic Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Biopharmaceutical Logistic Market Size by Application (2020-2025)
6.4.3.2 Japan Biopharmaceutical Logistic Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
7 Key Players Profiles
7.1 Deutsche Post DHL
7.1.1 Deutsche Post DHL Company Details
7.1.2 Deutsche Post DHL Business Overview
7.1.3 Deutsche Post DHL Biopharmaceutical Logistic Introduction
7.1.4 Deutsche Post DHL Revenue in Biopharmaceutical Logistic Business (2020-2025)
7.1.5 Deutsche Post DHL Recent Development
7.2 Kuehne + Nagel
7.2.1 Kuehne + Nagel Company Details
7.2.2 Kuehne + Nagel Business Overview
7.2.3 Kuehne + Nagel Biopharmaceutical Logistic Introduction
7.2.4 Kuehne + Nagel Revenue in Biopharmaceutical Logistic Business (2020-2025)
7.2.5 Kuehne + Nagel Recent Development
7.3 FedEx
7.3.1 FedEx Company Details
7.3.2 FedEx Business Overview
7.3.3 FedEx Biopharmaceutical Logistic Introduction
7.3.4 FedEx Revenue in Biopharmaceutical Logistic Business (2020-2025)
7.3.5 FedEx Recent Development
7.4 AmerisourceBergen
7.4.1 AmerisourceBergen Company Details
7.4.2 AmerisourceBergen Business Overview
7.4.3 AmerisourceBergen Biopharmaceutical Logistic Introduction
7.4.4 AmerisourceBergen Revenue in Biopharmaceutical Logistic Business (2020-2025)
7.4.5 AmerisourceBergen Recent Development
7.5 UPS (Marken)
7.5.1 UPS (Marken) Company Details
7.5.2 UPS (Marken) Business Overview
7.5.3 UPS (Marken) Biopharmaceutical Logistic Introduction
7.5.4 UPS (Marken) Revenue in Biopharmaceutical Logistic Business (2020-2025)
7.5.5 UPS (Marken) Recent Development
7.6 DB Schenker
7.6.1 DB Schenker Company Details
7.6.2 DB Schenker Business Overview
7.6.3 DB Schenker Biopharmaceutical Logistic Introduction
7.6.4 DB Schenker Revenue in Biopharmaceutical Logistic Business (2020-2025)
7.6.5 DB Schenker Recent Development
7.7 XPO Logistics
7.7.1 XPO Logistics Company Details
7.7.2 XPO Logistics Business Overview
7.7.3 XPO Logistics Biopharmaceutical Logistic Introduction
7.7.4 XPO Logistics Revenue in Biopharmaceutical Logistic Business (2020-2025)
7.7.5 XPO Logistics Recent Development
7.8 Panalpina
7.8.1 Panalpina Company Details
7.8.2 Panalpina Business Overview
7.8.3 Panalpina Biopharmaceutical Logistic Introduction
7.8.4 Panalpina Revenue in Biopharmaceutical Logistic Business (2020-2025)
7.8.5 Panalpina Recent Development
7.9 Nippon Express
7.9.1 Nippon Express Company Details
7.9.2 Nippon Express Business Overview
7.9.3 Nippon Express Biopharmaceutical Logistic Introduction
7.9.4 Nippon Express Revenue in Biopharmaceutical Logistic Business (2020-2025)
7.9.5 Nippon Express Recent Development
7.10 GEODIS
7.10.1 GEODIS Company Details
7.10.2 GEODIS Business Overview
7.10.3 GEODIS Biopharmaceutical Logistic Introduction
7.10.4 GEODIS Revenue in Biopharmaceutical Logistic Business (2020-2025)
7.10.5 GEODIS Recent Development
7.11 VersaCold
7.11.1 VersaCold Company Details
7.11.2 VersaCold Business Overview
7.11.3 VersaCold Biopharmaceutical Logistic Introduction
7.11.4 VersaCold Revenue in Biopharmaceutical Logistic Business (2020-2025)
7.11.5 VersaCold Recent Development
7.12 Agility
7.12.1 Agility Company Details
7.12.2 Agility Business Overview
7.12.3 Agility Biopharmaceutical Logistic Introduction
7.12.4 Agility Revenue in Biopharmaceutical Logistic Business (2020-2025)
7.12.5 Agility Recent Development
7.13 DSV
7.13.1 DSV Company Details
7.13.2 DSV Business Overview
7.13.3 DSV Biopharmaceutical Logistic Introduction
7.13.4 DSV Revenue in Biopharmaceutical Logistic Business (2020-2025)
7.13.5 DSV Recent Development
7.14 Sinotrans
7.14.1 Sinotrans Company Details
7.14.2 Sinotrans Business Overview
7.14.3 Sinotrans Biopharmaceutical Logistic Introduction
7.14.4 Sinotrans Revenue in Biopharmaceutical Logistic Business (2020-2025)
7.14.5 Sinotrans Recent Development
7.15 Kerry Logistics
7.15.1 Kerry Logistics Company Details
7.15.2 Kerry Logistics Business Overview
7.15.3 Kerry Logistics Biopharmaceutical Logistic Introduction
7.15.4 Kerry Logistics Revenue in Biopharmaceutical Logistic Business (2020-2025)
7.15.5 Kerry Logistics Recent Development
7.16 SF Express
7.16.1 SF Express Company Details
7.16.2 SF Express Business Overview
7.16.3 SF Express Biopharmaceutical Logistic Introduction
7.16.4 SF Express Revenue in Biopharmaceutical Logistic Business (2020-2025)
7.16.5 SF Express Recent Development
7.17 CEVA
7.17.1 CEVA Company Details
7.17.2 CEVA Business Overview
7.17.3 CEVA Biopharmaceutical Logistic Introduction
7.17.4 CEVA Revenue in Biopharmaceutical Logistic Business (2020-2025)
7.17.5 CEVA Recent Development
7.18 CH Robinson
7.18.1 CH Robinson Company Details
7.18.2 CH Robinson Business Overview
7.18.3 CH Robinson Biopharmaceutical Logistic Introduction
7.18.4 CH Robinson Revenue in Biopharmaceutical Logistic Business (2020-2025)
7.18.5 CH Robinson Recent Development
7.19 Air Canada Cargo
7.19.1 Air Canada Cargo Company Details
7.19.2 Air Canada Cargo Business Overview
7.19.3 Air Canada Cargo Biopharmaceutical Logistic Introduction
7.19.4 Air Canada Cargo Revenue in Biopharmaceutical Logistic Business (2020-2025)
7.19.5 Air Canada Cargo Recent Development
8 Biopharmaceutical Logistic Market Dynamics
8.1 Biopharmaceutical Logistic Industry Trends
8.2 Biopharmaceutical Logistic Market Drivers
8.3 Biopharmaceutical Logistic Market Challenges
8.4 Biopharmaceutical Logistic Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer

Companies Mentioned: 

Deutsche Post DHL
Kuehne + Nagel
FedEx
AmerisourceBergen
UPS (Marken)
DB Schenker
XPO Logistics
Panalpina
Nippon Express
GEODIS
VersaCold
Agility
DSV
Sinotrans
Kerry Logistics
SF Express
CEVA
CH Robinson
Air Canada Cargo

License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

Ìý

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

Ìý

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/mrrpb5/global-biopharmaceutical-logistic-sales-market-report-competitive-analysis-and-regional

Links
[1] /countries/global[2] /it-services[3] /computing-electronics